Potential predictors | FEV1 % | DSS change |
Age | −0.14* | −0.036 |
Duration of asthma | −0.085* | −0.0011 |
Per cent predicted FEV1 at baseline | −0.15* | 0.053* |
Per cent reversibility of FEV1 at baseline | 0.28* | −0.022 |
β-agonist use at baseline | 0.039 | −0.091* |
FEV1 at baseline | −0.033 | 0.079* |
DSS at baseline | 0.033 | −0.28* |
PEFAM at baseline | 0.073* | 0.042 |
β-agonist use % at week 3# | −0.20* | 0.34* |
FEV1 % at week 3# | 0.58* | −0.24* |
DSS change at week 3¶ | −0.27* | 0.71* |
PEFAM change at week 3¶ | 0.23* | −0.24* |
FEV1: forced expiratory volume in one second
DSS: daytime symptom score
PEFAM: morning peak expiratory flow
#: per cent change from baseline
¶: change from baseline
*: p<0.05